IDENTIFICATION OF A 17-HYDROXYPROGESTERONE-BINDING IMMUNOGLOBULIN IN THE SERUM OF A WOMAN WITH PERIODIC RASHES
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
Researchers identified a 17-hydroxyprogesterone-binding IgG in the serum of a woman with periodic rashes, representing the first characterization of an antibody to an endogenous steroid in human serum.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
A 30-year-old patient with primary infertility had a history of recurrent oral and perineal rashes that appeared just prior to the midcycle rise in basal body temperature and subsided with the onset of menses. The rashes did not appear during periods of treatment with oral contraceptives or danazol, and were suppressed by administration of cortisol. Sera obtained during the follicular and luteal phases of her cycle were found to contain a progestin-binding component with high affinity for 17-hydroxyprogesterone and a somewhat lower affinity for progesterone. Analysis of these sera showed the progestin-binding component to have properties of IgG, with an apparent binding affinity for 17-hydroxyprogesterone of 2 X 10(10) M-1. This report is the first characterization of an antibody to an endogenous steroid in human serum.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (1)
References (9)
- doi:10.1016/b978-0-12-571126-5.50005-4 via openalex
- doi:10.1001/archderm.1951.01570030091012 via openalex
- doi:10.1210/jcem-49-3-406 via openalex
- doi:10.1016/0039-128x(78)90111-3 via openalex
- doi:10.1016/0091-6749(71)90025-x via openalex
- W103383249 via openalex
- doi:10.1016/0003-2697(67)90297-7 via openalex
- doi:10.1016/s0076-6879(69)15043-0 via openalex
- doi:10.1016/0021-8707(45)90035-9 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-11T03:58:47.732477+00:00
- unpaywall
- last seen: 2026-09-22T06:12:16.469521+00:00
License: CC0
· commercial use OK